Yuying Liu

发表

Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways.

S. Grant, S. T. Eblen, Qianbin Li, 2010, Bioorganic & medicinal chemistry letters.

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

A. Sood, C. Landen, S. T. Eblen, 2014, Carcinogenesis.

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system on the human tumor cell growth

Z. Wang, Qingzhen Zhao, Jun Yang, 2003 .

The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

C. V. Van Pelt, M. Rosenblum, Yuying Liu, 2006, Neoplasia.

Recombinant single‐chain antibody fusion construct targeting human melanoma cells and containing tumor necrosis factor

M. Rosenblum, Yuying Liu, J. W. Marks, 2004, International journal of cancer.

GM-CSF Antibodies and Peripheral Treg Cells as Potential Markers of Disease Activity to Guide Therapeutic Decisions in Pediatric IBD

Fern, Yuying Liu, L. Denson, 2018 .

Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.

M. Rosenblum, Yuying Liu, J. W. Marks, 2003, Cancer research.

Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.

R. Meyn, M. Rosenblum, Yuying Liu, 2006, Neoplasia.

Locally activity-released bifunctional fusion protein enhances antithrombosis and alleviates bleeding risk

Yuying Liu, Chutse Wu, Jide Jin, 2007, Journal of Thrombosis and Thrombolysis.

Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents.

W. Hittelman, M. Rosenblum, Yuying Liu, 2003, Molecular cancer therapeutics.

Expression of adenovirus type 5 E1A in the methylotrophic yeast Pachia pastoris and the inhibitory effect on S-180 tumor growth.

Z. Wang, Qingzhen Zhao, Yuying Liu, 2003, Biological & pharmaceutical bulletin.

Specific, pro-poptotic cell-signaling: Design of novel, recombinant targeted antitumor agents operating exclusively through modulation of cellular apoptotic events novel, targeted pro-apoptotic therapeutic agents

M. Rosenblum, Yuying Liu, L. Cheung, 2005 .

Cloning of aminopeptidase N promoter and its activity in hematopoietic cell and different tumor cell lines

Qingzhen Zhao, Jun Yang, Yuying Liu, 2001 .

Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion

S. Weed, S. T. Eblen, Hui Zheng, 2013, Nucleic acids research.

Inhibitory effect of a modified adenovirus type 5E1A gene on the NF-κB activity in porcine aortic endothelial cells induced by TNF-α

Qingzhen Zhao, Jun Yang, Yuying Liu, 2003 .

Mitogen-Activated Protein Kinase Phosphorylation of Splicing Factor 45 (SPF45) Regulates SPF45 Alternative Splicing Site Utilization, Proliferation, and Cell Adhesion

S. T. Eblen, Hui Zheng, Yuying Liu, 2012, Molecular and Cellular Biology.

Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells

S. T. Eblen, Mandi M. Murph, Yuying Liu, 2013, PloS one.

Bax345/BLyS: a novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin.

W. Hittelman, M. Rosenblum, Yuying Liu, 2012, Cancer letters.

Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cells.

M. Rosenblum, Yuying Liu, P. Thorpe, 2003, Molecular cancer therapeutics.

Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.

Yuying Liu, Yuefang Wang, L. Dong, 2019, Cancer biotherapy & radiopharmaceuticals.

Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition

E. Wiemer, Yuying Liu, Junqing Ma, 2021, Theranostics.

[MnSOD gene regulated by aminopeptidase N promoter specifically protects bone marrow from radiation].

Z. Wang, Jun Yang, Yuying Liu, 2002, Ai zheng = Aizheng = Chinese journal of cancer.

Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma

Yuying Liu, Hui Zhu, Liping Jiang, 2018, PloS one.

Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.

B. Aggarwal, W. Hittelman, M. Rosenblum, 2010, Neoplasia.

Mechanistic studies of a novel human fusion toxin composed of vascular endothelial growth factor (VEGF)121 and the serine protease granzyme B: directed apoptotic events in vascular endothelial cells.

M. Rosenblum, Yuying Liu, P. Thorpe, 2003, Molecular cancer therapeutics.

Cited Articles Citing Articles E-mail Alerts Design, Expression, Purification, and Characterization, in Vitro and in Vivo, of an Antimelanoma Single-chain Fv Antibody Fused to the Toxin Gelonin

M. Rosenblum, Yuying Liu, J. W. Marks, 2022 .